How many insider trades does FilingIQ track for IMNN?

FilingIQ tracks 25 Form 4 insider transactions for IMNN (Imunon, Inc.), covering filings from Dec 7, 2023 onwards. 6 of those were filed in the last 90 days.

Are IMNN insiders net buyers or net sellers?

Across the full Form 4 history for IMNN, 3 transactions (12%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does IMNN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is IMNN in?

Imunon, Inc. (IMNN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.95M.

IMNN insider trading

NasdaqCM Healthcare

Imunon, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

12% / 0%

Market cap

$10.95M

About Imunon, Inc.

Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Company website: imunon.com

IMNN insider activity at a glance

FilingIQ has scored 25 insider transactions for IMNN since Dec 7, 2023. The most recent filing in our index is dated May 22, 2026.

Across the full history, 3 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on IMNN insider trades is 68.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live IMNN trades on FilingIQ Raw filings on SEC EDGAR

Latest IMNN Form 4 filings

Lindborg Stacy President and CEO

P Aug 15, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,265

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 195

Guardant Health, Inc.

ADPT 184

Adaptive Biotechnologies Corp

BMY 182

BRISTOL MYERS SQUIBB CO

VTRS 165

Viatris Inc

ALNY 153

ALNYLAM PHARMACEUTICALS, INC.

Frequently asked

How many insider trades does FilingIQ track for IMNN?: FilingIQ tracks 25 Form 4 insider transactions for IMNN (Imunon, Inc.), covering filings from Dec 7, 2023 onwards. 6 of those were filed in the last 90 days.
Are IMNN insiders net buyers or net sellers?: Across the full Form 4 history for IMNN, 3 transactions (12%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does IMNN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is IMNN in?: Imunon, Inc. (IMNN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $10.95M.

Methodology & sources

Every IMNN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.